Author:
Wang ChunPeng,Liu XiaoHui,Guo ShiWen
Abstract
Abstract
Background
An anti-tumour activity has been demonstrated for α-solanine, a bioactive compound extracted from the traditional Chinese herb Solanum nigrum L. However, its efficacy in the treatment of gliomas and the underlying mechanisms remain unclear. The aim of this study was to investigate the inhibitory effects of α-solanine on glioma and elucidate its mechanisms and targets using network pharmacology, molecular docking, and molecular biology experiments.
Methods
Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was utilized to predict the potential targets of α-solanine. GeneCards was used to gather glioma-related targets, and the STRING online database was used to analyze protein–protein interaction (PPI) networks for the shared targets. Hub genes were identified from the resulting PPI network and further investigated using Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Additionally, prognostic and gene set enrichment analyses (GSEA) were carried out to identify potential therapeutic targets and their underlying mechanisms of action in relation to the prognosis of gliomas. In vitro experiments were conducted to verify the findings from the network pharmacology analysis.
Results
A total of 289 α-solanine targets and 1149 glioma-related targets were screened, of which 78 were common targets. 11 hub genes were obtained, including SRC, HRAS, HSP90AA1, IGF1, MAPK1, MAPK14, KDR, STAT1, JAK2, MAP2K1, and IGF1R. The GO and KEGG pathway analyses unveiled that α-solanine was strongly associated with several signaling pathways, including positive regulation of MAP kinase activity and PI3K-Akt. Moreover, α-solanine (10 µM and 15 µM) inhibited the proliferation and migration but promoted the apoptosis of glioma cells. Finally, STAT1 was identified as a potential mediator of the effect of α-solanine on glioma prognosis.
Conclusion
α-Solanine can inhibit the proliferation and migration of gliomas by regulating multiple targets and signalling pathways. These findings lay the foundation for the creation of innovative clinical anti-glioma agents.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference63 articles.
1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. Cbtrus statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2005–2009. Neuro Oncol. 2012;14 Suppl 5(Suppl 5):1–49.
2. Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–9.
3. Meng XQ, Zhang W, Zhang F, Yin SY, Xie HY, Zhou L, et al. Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma hepg2 cells. Oncol Lett. 2016;11(3):2145–51.
4. Lv C, Kong H, Dong G, Liu L, Tong K, Sun H, et al. Antitumor efficacy of alpha-solanine against pancreatic cancer in vitro and in vivo. PLoS One. 2014;9(2):e87868.
5. Gao J, Ying Y, Wang J, Cui Y. Solanine inhibits immune escape mediated by hepatoma treg cells via the tgfbeta/smad signaling pathway. Biomed Res Int. 2020;2020:9749631.